Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Sambhaji S. Pisal
Serum Institute of India Private Ltd
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
145
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Immunogenicity of a Bivalent Paratyphoid A-Typhoid Conjugate Vaccine in Healthy Indian Adults: A Phase I, Randomized, Active Controlled Study
Number of pages: 26
Posted: 28 Aug 2023
Prasad S. Kulkarni
,
Anirudha Vyankatesh Potey
,
Sandesh Bharati
,
Anil Kunhihitlu
,
Bharath Narasimha
,
Y Sindhu
,
Abhijeet Dharmadhikari
,
Vinay Gavade
,
Chandrashekhar D. Kamat
,
Asha Dinesh Mallya
,
Annamraju D. Sarma
,
Sunil Goel
, Sambhaji S. Pisal,
Cyrus Poonawalla
,
Rajaram Venkatesan
,
Elizabeth Jones
,
Amy Flaxman
,
Young Chan Kim
,
Andrew J. Pollard
and
TCV-01 Study Group
Serum Institute of India Private Ltd, Serum Institute of India Pvt Ltd, Serum Institute of India Private Ltd, Syngene International Limited, Syngene International Limited, Syngene International Limited, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Serum Institute of India Private Ltd, Emmes India Pvt, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group and Independent
Downloads
145
(508,926)
Citation
1
View PDF
Download
Abstract:
Enteric fever, typhoid, paratyphoid, first-in-human
Feedback